$-0.01
(Market cap
$4 Mln
Recently Viewed
Clear AllMarket cap
$4 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
0.9
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
$-13 Mln
ROE
-3.3 %
ROCE
-- %
Industry P/E
46.76
EV/EBITDA
0
Debt to Equity
0
Book Value
$--
EPS
$--
Face value
--
Shares outstanding
6,461,230
CFO
$-137.59 Mln
EBITDA
$-187.75 Mln
Net Profit
$-199.93 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
RA Medical Systems (RMED)
| -93.6 | -29.3 | -46.7 | -94.0 | -89.5 | -88.0 | -- |
|
BSE Sensex*
| -9.2 | 6.9 | -6.5 | -4.2 | 8.0 | 9.1 | 11.6 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|
|
RA Medical Systems (RMED)
| -92.4 | -79.0 | -73.7 | -85.8 |
|
S&P Small-Cap 600
| -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 4.4 | 22.0 | 15.8 | 14.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Ra Medical Systems, Inc develops and delivers electrophysiology products to provide patients, hospitals, and physicians with technologies and solutions to improve the lives of patients with cardiac arrhythmias in the United States. The company's lead... product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also provides LockeT, a suture retention device; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device. Ra Medical Systems, Inc is based in Fort Mill, South Carolina. Read more
CEO & Director
Mr. Jonathan Will McGuire
Interim CFO, Principal Financial Officer & Principal Accounting Officer
Mr. Brian D. Conn
Headquarters
Carlsbad, CA
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of RA Medical Systems (RMED) is $0.38 (NYSE) as of 19-Oct-2023 09:30 EDT. RA Medical Systems (RMED) has given a return of -89.47% in the last 3 years.
Since, TTM earnings of RA Medical Systems (RMED) is negative, P/E ratio is not available.
The P/B ratio of RA Medical Systems (RMED) is 0.86 times as on 19-Oct-2023, a 73 discount to its peers’ median range of 3.24 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2022
|
--
|
--
|
|
2021
|
--
|
--
|
|
2020
|
--
|
--
|
|
2019
|
--
|
--
|
|
2018
|
--
|
--
|
The 52-week high and low of RA Medical Systems (RMED) are Rs -- and Rs -- as of 01-May-2026.
RA Medical Systems (RMED) has a market capitalisation of $ 4 Mln as on 19-Oct-2023. As per SEBI classification, it is a Small Cap company.
Before investing in RA Medical Systems (RMED), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.